Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
about
The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients.Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsDaily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.Considerations for dosing immunoglobulin in obese patients.Comprehensive Guidance for Antibiotic Dosing in Obese Adults.A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.Antibiotic dosing in obesity: a BIG challenge.A simulation of loading doses for vancomycin continuous infusion regimens in intensive care.Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
P2860
Q33763123-EECC07BF-29CC-4F32-9D9E-8E592934519DQ37120024-988F5D09-BBD3-459B-9FBE-F0849E4AFCE7Q37358623-C9D7EA17-7E7B-4D36-8A5D-395488173076Q38625059-B4368543-198E-4AAA-9F00-EC1DCC6C776AQ38763496-AA07A06E-CD7A-4E55-8826-8666D327A977Q38882052-DF487E74-D82F-4B24-9578-04CBCEA214E3Q39040314-0D7FCD9A-E35F-417A-8526-F0EFE5622AA7Q39163785-FADC8314-C468-4942-99D2-5B89BA34E4C0Q40067964-294265FE-712A-4840-92F0-7AE0988219C5Q41676300-B9676873-44A6-429C-96E5-6F0DBA2DC73FQ42368757-C492745D-839E-45D9-891A-68A6BEB08298Q50647917-09A041EB-C988-47EF-A8AB-B074021D4235Q53822956-EDA57E72-7293-48BF-9DF1-627A36308279
P2860
Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of obesity on the pharm ...... patients: A structured review.
@en
type
label
Effect of obesity on the pharm ...... patients: A structured review.
@en
prefLabel
Effect of obesity on the pharm ...... patients: A structured review.
@en
P2093
P1476
Effect of obesity on the pharm ...... patients: A structured review.
@en
P2093
Abdulaziz S Alobaid
Fabio Silvio Taccone
Maya Hites
P304
P356
10.1016/J.IJANTIMICAG.2016.01.009
P577
2016-02-23T00:00:00Z